PUBLICATIONS

SELECTED PUBLICATIONS FROM DAVID KIRN, MD

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic livercancer: a phase I trial.

Park BH, Hwang T, Liu TC, Sze DY, Kim JS, Kwon HC, Oh SY, Han SY, Yoon JH, Hong SH, Moon A, Speth K, Park C, Ahn YJ, Daneshmand M, Rhee BG, Pinedo HM, Bell JC, Kirn DH.
Lancet Oncol. 2008 Jun;9(6):533-42.

MicroRNAs fine-tune oncolytic viruses.

Bell JC, Kirn D.
Nature Biotechnology. 2008 Dec;26(12):1346-8.







SELECTED PUBLICATIONS FROM DAVID SCHAFFER, PHD

In Vivo Selection of a Computationally Designed SCHEMA AAV Library Yields a Novel Variant for Infection of Adult Neural Stem Cells in the SVZ

Ojala DS, Sun S, Santiago-Ortiz JL, Shapro MG, Romero PA, Schaffer DV. In vivo selection of a computationally designed SCHEMA AAV library yields a novel variant for infection of adult neural stem cells in the SVZ. Mol Ther. 2018;26(1):304-319.

AAV ancestral reconstruction library enables selection of broadly infectious viral variants

Santiago-Ortiz J, Ojala DS, Westesson O, et al.  AAV ancestral reconstruction library enables selection of broadly infectious viral variants. Gene Ther. 2015;22(12):934-946.